Logo image of CERO

CERO THERAPEUTICS HOLDINGS I (CERO) Stock Income Statement

NASDAQ:CERO - Nasdaq - US71902K1051 - Common Stock

2.34  -0.15 (-6.02%)

After market: 2.44 +0.1 (+4.27%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)
Revenue
CERO Revenue ChartCERO Revenue over time chart
0.000.000.00
Operating Expenses
CERO Operating Expenses ChartCERO Operating Expenses over time chart
2.93M2.91M332.00K
Selling, General, and Administrative Expenses
CERO Selling, General, and Administrative Expenses ChartCERO Selling, General, and Administrative Expenses over time chart
2.93M2.91M332.00K
Operating Income
CERO Operating Income ChartCERO Operating Income over time chart
-2.93M-2.91M-332.00K
Interest Income/Expense
CERO Interest Income/Expense ChartCERO Interest Income/Expense over time chart
491.60K2.84M-400.00
Income Before Taxes
CERO Income Before Taxes ChartCERO Income Before Taxes over time chart
-2.44M-68.60K-332.40K
Income Tax
CERO Income Tax ChartCERO Income Tax over time chart
94.80K599.20K-16.90K
Net Income
CERO Net Income ChartCERO Net Income over time chart
-2.54M-667.70K-315.50K
 
Per Share Data
EPS Diluted Total Ops
CERO EPS Diluted Total Ops ChartCERO EPS Diluted Total Ops over time chart
-0.39-0.03-0.01
 
Statistics

All data in USD

Charts

CERO Income Statement data chartCERO Revenue, Operating Income, Net Income and EBITDA ChartIncome Statements 2021 2022 2023 -500K -1M -1.5M -2M -2.5M
CERO Earnings Per Share (EPS) chartCERO EPS Diluted and non-GAAP ChartEarnings Per Share 2021 2022 2023 -0.1 -0.2 -0.3